Chinese CMO

China’s Pharmaceutical “Sea Turtles” – Innovation or Imitation and Does It Matter?

During a discussion about the future direction of immuno-oncology pharmaceuticals at the Annual ChinaBio® Partnering Meeting held in Suzhou, China, last May, one point of disagreement among the panelists was whether the number of Chinese companies targeting development…


China’s Pilot Program Opens Door to Contract Drug Manufacturing

Fresh off launching our company at the CPhI Worldwide Congress in Madrid in October, PaizaBio began business development efforts as the aseptic CMO partner of choice for Western pharmaceutical companies seeking to expand their presence in the burgeoning…